Lisata Therapeutics Inc (LSTA)
3.025
-0.10
(-3.04%)
USD |
NASDAQ |
May 31, 16:00
3.16
+0.14
(+4.46%)
After-Hours: 20:00
Lisata Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2016 | -160.0% |
| December 31, 2015 | -439.1% |
| September 30, 2015 | -193.2% |
| June 30, 2015 | -291.9% |
| March 31, 2015 | -604.8% |
| December 31, 2014 | -220.1% |
| September 30, 2014 | -412.2% |
| June 30, 2014 | -280.8% |
| March 31, 2014 | -337.4% |
| December 31, 2013 | -307.4% |
| September 30, 2013 | -244.7% |
| June 30, 2013 | -196.7% |
| March 31, 2013 | -348.7% |
| December 31, 2012 | -563.6% |
| September 30, 2012 | -189.7% |
| June 30, 2012 | -608.1% |
| March 31, 2012 | -247.8% |
| December 31, 2011 | -447.3% |
| September 30, 2011 | -337.5% |
| June 30, 2011 | -479.7% |
| March 31, 2011 | -51.93% |
| December 31, 2010 | -34.13% |
| September 30, 2010 | -43.34% |
| June 30, 2010 | -27.69% |
| March 31, 2010 | -29.13% |
| Date | Value |
|---|---|
| December 31, 2009 | -108.6% |
| September 30, 2009 | -8.49K% |
| June 30, 2009 | -14.85K% |
| March 31, 2009 | -4.14K% |
| December 31, 2008 | -7.14K% |
| September 30, 2008 | -7.61K% |
| June 30, 2008 | -10.04K% |
| March 31, 2008 | -364.7K% |
| December 31, 2007 | -1.49K% |
| September 30, 2007 | -34.46K% |
| June 30, 2007 | -32.55K% |
| March 31, 2007 | -3.25K% |
| December 31, 2006 | -6.90K% |
| September 30, 2006 | -28.86K% |
| June 30, 2006 | -19.88K% |
| March 31, 2006 | -18.20K% |
| December 31, 2005 | -7.46K% |
| September 30, 2005 | -7.00K% |
| June 30, 2005 | -4.16K% |
| March 31, 2005 | -2.37K% |
| December 31, 2004 | -2.68K% |
| September 30, 2004 | -16.86K% |
| June 30, 2004 | -6.96K% |
| March 31, 2004 | -1.67K% |
| December 31, 2003 | -3.14K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Becton Dickinson & Co | 10.64% |
| Edwards Lifesciences Corp | 22.02% |
| AIM ImmunoTech Inc | -14.54K% |
| Protalix BioTherapeutics Inc | -122.6% |
| Armata Pharmaceuticals Inc | -- |